Back to Search Start Over

Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.

Authors :
Niessen, R. C.
Berends, M. J.
Wu, Y.
Sijimons, R. H.
Hollema, H.
Ligtenberg, M. J.
de Walle, H. E. K.
de Vries, E. G. E.
Karrenbeld, A.
Buys, C. H. C. M.
van der Zee, A. G. J.
Hofstra, R. M. W.
Kleibeuker, J. H.
Source :
Gut. Dec2006, Vol. 55 Issue 12, p1781-1788. 8p.
Publication Year :
2006

Abstract

Background: Patients with early-onset colorectal cancer (CRC) or those with multiple tumours associated with hereditary non-polyposis colorectal cancer (HNPCC) raise suspicion of the presence of germline DNA mismatch repair (MMR) gene mutations. Aim: To analyse the value of family history, microsatellite instability (MSI) analysis and MMR protein staining in the tumour to predict the presence of an MMR gene mutation in such patients. Methods: In 281 patients diagnosed with CRC before the age of 50 years or with CRC and at least one additional HNPCC-associated cancer, germline mutation analysis in MLH1, MSH2 and MSH6 was carried out with denaturing gradient gel electrophoresis and multiplex ligation-dependent probe amplification. MSI analysis with five consensus markers and MMR protein staining for MLH1, MSH2 and MSH6 were carried out in the tumours. Results: 25 pathogenic mutations (8 in MLH1, 9 in MSH2 and 8 in MSH6) were found. MSI analysis missed three and immunohistochemistry (IHC) missed two mutation carriers. Sensitivities of family history, MSI analysis and IHC for the presence of a mutation were 76%, 82% and 88%, specificities were 64%, 70% and 84%, and positive predictive values were 19%, 23% and 38%, respectively. Multivariate analysis showed the highest odds ratio for IHC (38.3, 95% confidence interval 9.0 to 184). Prevalence of pathogenic germline MMR gene mutations in patients with CRC before the age of 50 years was 6% and in those with ⩾2 HNPCC-associated tumours was 22%. In the second group, no mutation carriers were found among the 29 patients who were diagnosed with their first tumour after the age of 60 years. Conclusion: Family history, MSI analysis and IHC are indicative parameters to select patients with CRC for MMR gene mutation analysis. The data show that IHC is the best single selection criterion. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00175749
Volume :
55
Issue :
12
Database :
Academic Search Index
Journal :
Gut
Publication Type :
Academic Journal
Accession number :
23512276
Full Text :
https://doi.org/10.1136/gut.2005.090159